0001894153-22-000001.txt : 20220523 0001894153-22-000001.hdr.sgml : 20220523 20220523113710 ACCESSION NUMBER: 0001894153-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 EFFECTIVENESS DATE: 20220523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nomax Therapeutics, Inc CENTRAL INDEX KEY: 0001894153 IRS NUMBER: 862188907 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-422540 FILM NUMBER: 22950331 BUSINESS ADDRESS: STREET 1: 3363 NE 163 STREET STREET 2: SUITE 708 D CITY: NORTH MIAMI BEACH STATE: FL ZIP: 33160 BUSINESS PHONE: 305-331-1213 MAIL ADDRESS: STREET 1: 3363 NE 163 STREET STREET 2: SUITE 708 D CITY: NORTH MIAMI BEACH STATE: FL ZIP: 33160 FORMER COMPANY: FORMER CONFORMED NAME: Nomax Therapeitics, Inc DATE OF NAME CHANGE: 20211116 D/A 1 primary_doc.xml X0708 D/A LIVE 0001894153 Nomax Therapeutics, Inc 3363 NE 163 STREET SUITE 708 D NORTH MIAMI BEACH FL FLORIDA 33160 305-331-1213 FLORIDA Nomax Therapeitics, Inc Corporation true 2021 Max Temnik 3363 SE 163rd Street Ste 708 D Nort Miami Beach FL FLORIDA 33160 Executive Officer Biotechnology No Revenues 06b true 0001894153-21-000004 2021-10-18 true true false 1000000 10000000 300000 9700000 false 1 0 0 0 false Nomax Therapeutics, Inc Max Temnik Max Temnik President 2022-05-23